Breast cancer in special situations

Breast Care

Volumn 3, Issue 3, 2008, Pages 161-162

  Gerber, Bernd ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT THERAPY; BREAST CANCER; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; EDITORIAL; ESTROGEN SYNTHESIS; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; MALE; MALE BREAST; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT INDICATION; ULTRASOUND;

EID: 46849085016     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000138038     Document Type: Editorial

References (21)

1. AGO: www.ago-online.org. 2008.
2. NCCN (National Comprehensive Cancer Network): NCCN Practice Guidelines in Oncology: Breast Cancer. Version 2008. www.nccn.org.
3. ASCO: Clinical Practice Guidelines 2008. www.asco.org.
4. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007;18:1133-1144.
5. Newstead GM: MR imaging in the management of patients with breast cancer. Semin Ultrasound CT MR 2006;27:320-332.
6. Ko EY, Han BK, Shin JH, Kang SS: Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol 2007;8:382-389.
7. Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J: Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2007.
8. Krämer A, Hübner G, Schneeweiss A, Folprecht G, Neben K: Carcinoma of unknown primary - an orphan disease? Breast Care 2008;3:164-170.
9. Loibl S: New therapeutic options for breast cancer during pregnancy. Breast Care 2008;3:171-176.
10. Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN: Cancer incidence, mortality and prevalence worldwide 2002. http://www-dep.iarc.fr (2005).
11. Statistisches Bundesamt Deutschland 2008. www.destatis.de.
12. Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, Kurtz J, Sappino AP, Vlastos G: Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003;21:3580-3587.
13. Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M, Girre V, Brain E, Audisio RA, Bartelink H, Barton M, Giordano SH, Muss H, Aapro M: Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007;8:1101-1115.
14. Kemeny MM, Peterson BL, Kornblith AB, Muss HB, Wheeler J, Levine E, Bartlett N, Fleming G, Cohen HJ: Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003;21:2268-2275.
15. Aapro M: Mammography screening and treatment of breast cancer in the elderly. Breast Care 2008;3:177-182.
16. Rudlowski C: Male breast cancer. Breast Care 2008;3:183-189.
17. Fentiman IS, Fourquet A, Hortobagyi GN: Male breast cancer. Lancet 2006;367:595-604.
18. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN: Adjuvant systemic therapy for male breast carcinoma. Cancer 2005;104:2359-2364.
19. Reimer T: Management of rare histological types of breast cancer. Breast Care 2008;3:190-196.
20. Chia S, Swain SM, Byrd DR, Mankoff DA: Locally advanced and inflammatory breast cancer. J Clin Oncol 2008;26:786-790.
21. Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM: Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 2004;22:4067-4074.